# Vestre Viken Hospital Trust: Phase 4 study in Coronary Arterial Disease (CAD) (7000 participants)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Vestre Viken Hospital Trust |
| Sponsor type | Academic and hospital |
| Study | Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway |
| NCT ID | NCT07854795 |
| Phase | Phase 4 |
| Status | not yet recruiting |
| Conditions | Coronary Arterial Disease (CAD) |
| Intervention types | drug |
| Target enrollment | 7000 |
| Site countries | Norway |
| Posted | 2026-10-02 |
| Planned start | 2027-02-01 |
| Event | Newly registered study |
| Event date | 2026-10-02 |

## Why this score
- 7000 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07854795). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.